Humana's Quarterly Earnings Exceed Expectations Amid Market Pressures
On Wednesday, Humana reported better-than-expected quarterly earnings, attributed to effective management of medical costs. The company maintained its annual adjusted profit forecast, contrasting with some competitors who revised theirs upward. As a leading provider of Medicare Advantage plans for seniors and individuals with disabilities, Humana has been increasing its membership even as other major players reduce their presence in this market following persistent cost pressures over the past three years.
Cantor analyst Sarah James indicated potential challenges for Humana in the latter half of the year. In morning trading, Humana's stock experienced a 5% drop. Julie Utterback, a Morningstar analyst, suggested that maintaining an unchanged outlook for 2026, despite a robust start to the year, might have led to investor dissatisfaction.
In the first quarter, Humana reported an insurance segment benefit ratio of 89.4%, slightly better than its forecast of just under 90%. This metric is crucial for investors as it reflects the proportion of premiums spent on medical care. The company anticipates this ratio to be slightly above 91% in the second quarter, with trends in medical and pharmacy costs performing better than anticipated.
Humana noted a continuous discrepancy between the final rates for Medicare Advantage plan payments to private insurers and the actual healthcare expenditures incurred. The U.S. government announced a planned 2.48% average increase in payments to Medicare Advantage plan providers for older adults by 2027. To ensure steady margins, Humana plans to adjust benefits as necessary.
CEO Jim Rechtin commented on the consistency of medical service utilization and costs, while highlighting that the gap between these costs and federal funding has widened compared to the previous year. Rechtin stated, “Every year we’re going to step back and look at our whole portfolio. The practical reality is, all product, if priced appropriately, is good product.”
Humana has adjusted its annual adjusted profit expectation to at least $9 per share but revised its reported profit outlook to at least $8.36, down from an earlier estimate of $8.89. This adjustment reflects the impact of Medicare's Star Ratings, which influence bonuses for insurers. For the quarter, Humana achieved an adjusted profit per share of $10.31, surpassing the $10.19 estimate gathered by LSEG.